InvestorsHub Logo
Followers 4
Posts 506
Boards Moderated 0
Alias Born 03/30/2013

Re: None

Thursday, 08/14/2014 10:18:34 AM

Thursday, August 14, 2014 10:18:34 AM

Post# of 57850
Well guys - I am a huge believer in their products, they are A+. HOWEVER this report has forced a break-up.

They stated that they had orders for 120k cases of CW then reported sales in Q2 of only 21k cases? no explanation

Q2 case sales were supposed to triple Q1

The company needs capital to work with retailers to spotlight their products to get pass through.

Company hasn't hit a projection (was giving that time because its a tough industry lets face it)

Since this letter to shareholders didn't address capital one can only be led to believe that a line of credit is not in the offing and thus will or can only result in additional dilution.

Q2 should be the high point of the year and to me 125k cases is not good enough especially when coupled with previous statements

If Q3 is worse than Q2 then we are looking down the barrel of another tax loss selling season in Q4. Last year I waited for that to buy in... it worked out very well.

I am selling at a loss (average basis of .41) and will watch the stock but I couldn't wait to see if answers were forthcoming on the above issues since none were present in the letter to shareholders, where they should be). IT IS POSSIBLE THAT THEY DIDN'T MENTION ANYTHING ABOUT A LINE OF CREDIT BECAUSE ITS NOT DONE YET. ITS ALSO POSSIBLE THAT THE ORDERS FOR 120K CASES RELATED TO WALMART AND THEY WILL CONVERT TO SALES IN Q3. IF THOSE THINGS HAPPEN THE STOCK GOES UP SOLIDLY IMO AND I WILL/MAY MISS OUT. THAT IS THE PRICE WE PAY WHEN WE INVEST, WE CAN'T WIN THEM ALL BUT AS OF THIS MOMENT I HAVE CHOSEN TO LIMIT MY EXPOSURE/LOSS BASED UPON INFORMATION CURRENTLY AVAILABLE.

GLTA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.